Tambong, Marilou .

HRN: 27-85-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFTAZIDIME 1GM (VIAL)
09/25/2025
10/02/2025
IV
1 Gm
Q 6h
DM Foot, Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueCardiovascular    Compliance to guidelines: Compliant To Guidelines